BCSF on NYSE
Bain Capital Specialty Finance, Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement in the latest annual report, as filed.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Dividend income | $22.3M | $28.7M | $35.8M |
| Total investment income | $273.2M | $292.7M | $297.8M |
| Interest and debt financing expenses | $80.6M | $74.7M | $80.0M |
| Base management fee | $37.2M | $35.6M | $36.1M |
| Incentive fee | $18.1M | $28.9M | $25.5M |
| Professional fees | $2.9M | $3.5M | $2.6M |
| Directors fees | $720.0K | $695.0K | $716.0K |
| Other general and administrative expenses | $8.4M | $10.1M | $8.0M |
| Total expenses, net of fee waivers | $147.9M | $153.5M | $152.8M |
| Net investment income before taxes | $125.3M | $139.2M | $145.0M |
| Income tax expense, including excise tax | $3.8M | $4.5M | $3.4M |
| Net investment income | $121.6M | $134.7M | $141.6M |
| Net realized gain (loss) | -$28.2M | -$10.4M | -$43.9M |
| Net realized gain (loss) on foreign currency transactions | $761.0K | -$320.0K | -$5.1M |
| Net realized gain (loss) on forward currency exchange contracts | -$5.8M | $2.3M | -$407.0K |
| Net change in unrealized appreciation on foreign currency translation | $1.4M | -$251.0K | $4.0M |
| Net change in unrealized appreciation on forward currency exchange contracts | -$12.6M | $5.8M | -$2.3M |
| Net change in unrealized appreciation on investments | $21.6M | -$12.3M | $29.5M |
| Total net gain (loss) | -$22.8M | -$15.3M | -$18.2M |
| Net increase in net assets resulting from operations | $98.8M | $119.4M | $123.4M |
| Basic and diluted net investment income per share of common stock | $1.88 | $2.09 | $2.19 |
| Basic increase in net assets resulting from operations per share of common stock | $1.53 | $1.85 | $1.91 |
| Diluted increase in net assets resulting from operations per share of common stock | $1.53 | $1.85 | $1.91 |
| Basic weighted average common stock outstanding | 64.8M shares | 64.6M shares | 64.6M shares |
| Diluted weighted average common stock outstanding | 64.8M shares | 64.6M shares | 64.6M shares |
Every line of the balance sheet in the latest annual report, as filed.6
| Period ending | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Investments at fair value | $2.5B | ||
| Cash and cash equivalents | $23.1M | ||
| Foreign cash (cost of $2,477 and $2,640, respectively) | $3.2M | ||
| Restricted cash and cash equivalents | $32.7M | ||
| Collateral on derivatives | $11.0M | ||
| Deferred financing costs | $3.5M | ||
| Interest receivable on investments | $38.0M | ||
| Interest rate swap | $8.0M | ||
| Receivable for sales and paydowns of investments | $28.9M | ||
| Prepaid insurance | $489.0K | ||
| Unrealized appreciation on forward currency exchange contracts | $0 | ||
| Dividend receivable | $5.4M | ||
| Total Assets | $2.7B | ||
| Debt (net of unamortized debt issuance costs of $10,110 and $4,929, respectively) | $1.5B | ||
| Interest payable | $12.4M | ||
| Payable for investments purchased | $2.1M | ||
| Collateral payable on derivatives | $12.9M | ||
| Unrealized depreciation on forward currency exchange contracts | $9.1M | ||
| Base management fee payable | $9.4M | ||
| Incentive fee payable | $5.9M | ||
| Accounts payable and accrued expenses | $12.9M | ||
| Distributions payable | $9.7M | ||
| Total liabilities | $1.5B | ||
| Common stock, par value $0.001 per share, 100,000,000,000 and 100,000,000,000 shares authorized, 64,868,507 and 64,562,265 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | $65.0K | ||
| Paid in capital in excess of par value | $1.2B | ||
| Total distributable loss | -$43.8M | ||
| Total Net Assets | $1.1B | ||
| Total Liabilities and Total Net Assets | $2.7B | ||
| Net asset value per share | $17.23 | $17.40 | $17.56 |
| Investments, amortized cost | $2.5B | ||
| Unamortized debt issuance costs | $10.1M | ||
| Common stock, par value per share (in dollars per share) | $0.00 | ||
| Common stock, shares authorized (in shares) | 100.0B shares | ||
| Common stock, shares issued | 64.9M shares | ||
| Common stock, outstanding | 64.9M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net increase in net assets resulting from operations | $98.8M | $119.4M | $123.4M |
| Purchases of investments | -$1.3B | -$1.6B | -$844.3M |
| Proceeds from principal payments and sales of investments | $1.2B | $1.5B | $937.6M |
| Net realized loss from investments | $28.2M | $10.4M | $43.9M |
| Net realized (gain) loss on foreign currency transactions | -$761.0K | $320.0K | $5.1M |
| Net change in unrealized appreciation on forward currency exchange contracts | $12.6M | -$5.8M | $2.3M |
| Net change in unrealized appreciation on investments | -$21.6M | $12.3M | -$29.5M |
| Net change in unrealized appreciation on foreign currency translation | -$1.4M | $251.0K | -$4.0M |
| Increase in investments due to PIK | -$33.9M | -$26.2M | -$22.8M |
| Accretion of discounts and amortization of premiums | -$5.2M | -$5.1M | -$5.3M |
| Amortization of deferred financing costs and debt issuance costs | $5.2M | $4.0M | $3.6M |
| Collateral on derivatives | -$1.2M | -$2.1M | $2.0M |
| Interest receivable on investments | $1.1M | -$2.0M | -$2.9M |
| Interest rate swap | -$70.0K | $0 | $0 |
| Prepaid insurance | -$292.0K | $13.0K | -$16.0K |
| Dividend receivable | $391.0K | $3.7M | $4.3M |
| Interest payable | -$1.5M | $577.0K | $1.2M |
| Collateral payable on derivatives | $12.9M | $0 | $0 |
| Base management fee payable | $248.0K | $231.0K | $23.0K |
| Incentive fee payable | $1.2M | -$2.6M | -$1.9M |
| Accounts payable and accrued expenses | -$1.9M | $5.2M | $6.6M |
| Net cash provided by (used in) operating activities | $29.5M | -$27.1M | $219.3M |
| Borrowings on debt | $1.3B | $867.0M | $348.0M |
| Repayments on debt | -$1.2B | -$735.3M | -$480.0M |
| Payments of financing costs | -$9.3M | -$3.2M | $0 |
| Proceeds from issuances of common stock (net of offering and underwriting costs) | $4.6M | $0 | $0 |
| Purchase of common shares issued in connection with dividend reinvestment plan | $924.0K | $0 | $0 |
| Stockholder distributions paid | -$145.8M | -$114.3M | -$99.4M |
| Net cash provided by (used in) financing activities | -$71.9M | $14.3M | -$231.4M |
| Net decrease in cash, foreign cash, restricted cash and cash equivalents | -$42.4M | -$12.8M | -$12.2M |
| Effect of foreign currency exchange rates | $2.2M | -$571.0K | -$1.1M |
| Cash interest paid during the period | $76.9M | $70.1M | $75.3M |
| Cash paid for excise taxes during the period | $3.3M | $2.2M | $834.0K |
| Cash paid for state income taxes during the period | $0 | $163.0K | $382.0K |
Compare Bain Capital Specialty Finance, Inc. with another company
Former names
- Sankaty Capital CorpOct 13, 2015 to Apr 1, 20162
Recent filings
- Aug 10, 202610-Q
- Aug 10, 20268-K
- Jul 31, 20268-K
- Jul 23, 20268-K
- May 22, 20268-K
- May 12, 20268-K
- May 11, 202610-Q
- Apr 29, 20268-K
- Apr 27, 2026SCHEDULE 13G/A
- Apr 20, 2026DEF 14A
- Apr 3, 202640-17G
- Mar 5, 20263
- Mar 3, 20264 PRIMARY DOCUMENT
- Feb 27, 202610-K
- Feb 27, 20268-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8